Health Trials

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

ConditionsThrombocytopeniaSplenectomy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorInstitute of Hematology & Blood Diseases Hospital, China

About this trial

Evaluation of immune status before and after splenectomy in immune thrombocytopenia patients.

Eligibility criteria

Qualifiers

Aged 18 to 60 years old, male or female;

Conform to the diagnostic criteria of immune Thrombocytopenia (ITP)

Needed splenectomy;

People who are willing to sign the informed consent voluntarily and follow the research program.

Disqualifiers

Secondary thrombocytopenic purpura;

Patients with poor compliance;

Researchers believe that patients should not participate in the test of any other condition.

Trial design

Treatments tested in this trial

  • splenectomy

Treatment groups

50 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Institute of Hematology & Blood Diseases Hospital, China

Lead sponsor

Source ClinicalTrials.gov